Seventh JCA-AACR Special Joint Conference on the Latest Advances in Pancreatic Cancer Research: From Basic Science to Therapeutics

June 9-11, 2020
Kyoto Tokyu Hotel
Kyoto, Japan

Abstract Submission Deadline: Thursday, April 9, 2020
Registration Deadline: Friday, May 8, 2020

Organizing Committee

Kohei Miyazono,
The University of Tokyo, Tokyo, Japan
Masanobu Oshima,
Kanazawa University Cancer Research Institute, Kanazawa, Japan
Hiroshi Seno,
Kyoto University, Kyoto, Japan

Elizabeth M. Jaffee, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, USA
Anirban Maitra,
The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Rosalie C. Sears,
Oregon Health & Science University, Portland, Oregon, USA

Topics to include:

  1. Genetics, Kras, p53, and oncogenic signaling
  2. Tumor heterogeneity, plasticity, and therapy resistance
  3. Stromal evolution, and tumor microenvironment cross-talk and modeling
  4. Inflammation
  5. Immunotherapy
  6. Metabolism, anti-oxidants, and cachexia
  7. Screening and early detection, liquid biopsy, biomarkers, and premalignant lesions
  8. Clinical oncology and targeted therapies

The JCA and AACR are proud to jointly present this Seventh JCA-AACR Special Joint Conference. This collaboration will bring together basic scientists and clinical researchers from the United States, Japan, and around the world to share the latest and most exciting developments in pancreatic cancer research. The conference will offer ample opportunities for the scientific discussions and interactions that are necessary to make further basic research and clinical progress in the field.